Philip Rodoni - 20 Dec 2023 Form 4 Insider Report for Rubicon Technologies, Inc. (RBTC)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
22 Dec 2023, 20:19:35 UTC
Prior SEC filing
19 Dec 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Philip Rodoni

Key filing fact

Philip Rodoni filed Form 4 for Rubicon Technologies, Inc. (RBTC) on 22 Dec 2023.

Key facts

  • This page summarizes Philip Rodoni's Form 4 filing for Rubicon Technologies, Inc. (RBTC).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 22 Dec 2023, 20:19.

Change

  • Previous filing in this sequence was filed on 19 Dec 2023.
  • Current net transaction value: -$247,333.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RBT transaction

Class A Common Stock

Tax liability

Transaction value
$138,225
Shares
-94,798
Change %
-17%
Price
$1.46
Shares after
451,502
Date
22 Dec 2023
Ownership
Direct
Footnotes
F1
RBT transaction

Class A Common Stock

Tax liability

Transaction value
$109,108
Shares
-74,829
Change %
-17%
Price
$1.46
Shares after
376,673
Date
22 Dec 2023
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents the withholding of shares to cover tax withholding obligations associated with the vesting and settlement of restricted stock units.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .